| Type | Public |
| HQ | Shanghai, CN |
| Founded | 2013 |
| Size (employees) | 21 (est) |
| Website | zailaboratory.com |
ZAI Lab was founded in 2013 and is headquartered in Shanghai, CN
Report incorrect company information
Viewing summary data as a guest
Sign up for free to see all dataKey People/Management at ZAI Lab
Samantha Du
CEO
Report incorrect company information
ZAI Lab Office Locations
ZAI Lab has offices in Shanghai, Suzhou and Chaoyang
Report incorrect company information
ZAI Lab Financials and Metrics
ZAI Lab Revenue
| USD | |
|---|---|
Net income (FY, 2016) | (37.5m) |
EBIT (FY, 2016) | (38.5m) |
Market capitalization (17-Jan-2019) | 1.3b |
Closing stock price (17-Jan-2019) | 26.1 |
Cash (31-Dec-2016) | 83.9m |
ZAI Lab's current market capitalization is $1.3 b.
- Source: SEC Filings
| USD | FY, 2015 | FY, 2016 |
|---|---|---|
General and administrative expense | 2.8m | 6.4m |
R&D expense | 13.6m | 32.1m |
Operating expense total | 13.6m | 32.1m |
EBIT | (16.3m) | (38.5m) |
- Source: SEC Filings
| USD | FY, 2015 | FY, 2016 |
|---|---|---|
Cash | 13.2m | 83.9m |
Total Assets | 13.9m | 88.9m |
Current Liabilities | 3.9m | 5.2m |
Non-Current Liabilities | 62.0k | 778.0k |
| USD | FY, 2015 | FY, 2016 |
|---|---|---|
Cash From Operating Activities | (11.5m) | (32.2m) |
Cash From Investing Activities | (738.0k) | (2.7m) |
Cash From Financing Activities | 18.3m | 106.2m |
Net Change in Cash | 6.0m | 70.8m |
| USD | Y, 2016 |
|---|---|
Financial Leverage | -1.7 x |
Report incorrect company information
ZAI Lab News and Updates
January 09, 2019
Zai Lab Completes Enrollment of China Pivotal Trial of Niraparib as Second-Line Maintenance Therapy for Ovarian Cancer in China
SHANGHAI, China, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, today announced completion of patient enrollment of its pivotal trial of niraparib (ZL-2306; ZEJULA®) in development for second-line maintenanc…
December 28, 2018
Zai Lab Announces Launch of Optune® in Hong Kong for Patients with Glioblastoma Multiforme
First patient treated with Optune® providing new therapeutic option for an urgent and unmet clinical need
December 19, 2018
Zai Lab to Present at the 37th Annual J.P. Morgan Healthcare Conference
SHANGHAI, China, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that Dr. Samantha Du, Founder and Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Januar…
December 12, 2018
Zai Lab Announces Acceptance of NDA Submission of ZEJULA (Niraparib) in Mainland China by the NMPA
SHANGHAI, China, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for ZEJULA (nirapari…
November 29, 2018
MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENT™ Molecule in Greater China
ROCKVILLE, MD, and SHANGHAI, China, Nov. 29, 2018 (GLOBE NEWSWIRE) -- MacroGenics (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and Zai Lab Limited (NASDAQ: ZLAB), a …
Report incorrect company information
ZAI Lab Company Life and Culture
Report incorrect company information
ZAI Lab Frequently Asked Questions
When was ZAI Lab founded?
ZAI Lab was founded in 2013.
Who are ZAI Lab key executives?
ZAI Lab's key executives are Samantha Du.
How many employees does ZAI Lab have?
ZAI Lab has 21 employees.
Who are ZAI Lab competitors?
Competitors of ZAI Lab include Cesca Therapeutics, Celldex Therapeutics and Synthetic Biologics.
Where are ZAI Lab offices?
ZAI Lab has offices in Shanghai, Suzhou and Chaoyang.
How many offices does ZAI Lab have?
ZAI Lab has 3 offices.